Mrassf1a-Pap, a Novel Methylation-Based Assay for the Detection of Cell-Free Fetal DNA in Maternal Plasma

被引:9
|
作者
van den Oever, Jessica M. E. [1 ]
Balkassmi, Sahila [1 ]
Segboer, Tim [1 ]
Verweij, E. Joanne [2 ]
van der Velden, Pieter A. [3 ]
Oepkes, Dick [2 ]
Bakker, Egbert [1 ]
Boon, Elles M. J. [1 ]
机构
[1] Leiden Univ, Med Ctr, LDGA, Dept Clin Genet, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
关键词
NONINVASIVE-PRENATAL-DIAGNOSIS; PYROPHOSPHOROLYSIS-ACTIVATED POLYMERIZATION; PLACENTAL EPIGENETIC SIGNATURE; RASSF1A GENE; HYPERMETHYLATED RASSF1A; PCR; POLYMORPHISMS; RELIABILITY; MARKERS; ORIGIN;
D O I
10.1371/journal.pone.0084051
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: RASSF1A has been described to be differentially methylated between fetal and maternal DNA and can therefore be used as a universal sex-independent marker to confirm the presence of fetal sequences in maternal plasma. However, this requires highly sensitive methods. We have previously shown that Pyrophosphorolysis-activated Polymerization (PAP) is a highly sensitive technique that can be used in noninvasive prenatal diagnosis. In this study, we have used PAP in combination with bisulfite conversion to develop a new universal methylation-based assay for the detection of fetal methylated RASSF1A sequences in maternal plasma. Methods: Bisulfite sequencing was performed on maternal genomic (g) DNA and fetal gDNA from chorionic villi to determine differentially methylated regions in the RASSF1A gene using bisulfite specific PCR primers. Methylation specific primers for PAP were designed for the detection of fetal methylated RASSF1A sequences after bisulfite conversion and validated. Results: Serial dilutions of fetal gDNA in a background of maternal gDNA show a relative percentage of similar to 3% can be detected using this assay. Furthermore, fetal methylated RASSF1A sequences were detected both retrospectively as well as prospectively in all maternal plasma samples tested (n = 71). No methylated RASSF1A specific bands were observed in corresponding maternal gDNA. Specificity was further determined by testing anonymized plasma from non-pregnant females (n = 24) and males (n = 21). Also, no methylated RASSF1A sequences were detected here, showing this assay is very specific for methylated fetal DNA. Combining all samples and controls, we obtain an overall sensitivity and specificity of 100% (95% CI 98.4%-100%). Conclusions: Our data demonstrate that using a combination of bisulfite conversion and PAP fetal methylated RASSF1A sequences can be detected with extreme sensitivity in a universal and sex-independent manner. Therefore, this assay could be of great value as an addition to current techniques used in noninvasive prenatal diagnostics.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Early detection of cell-free fetal DNA in maternal plasma
    Illanes, S.
    Denbow, M.
    Kailasam, C.
    Finning, K.
    Soothill, P. W.
    EARLY HUMAN DEVELOPMENT, 2007, 83 (09) : 563 - 566
  • [2] A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer
    Wu, Xianrui
    Zhang, Yunfeng
    Hu, Tuo
    He, Xiaowen
    Zou, Yifeng
    Deng, Qiling
    Ke, Jia
    Lian, Lei
    He, Xiaosheng
    Zhao, Dezhi
    Cai, Xuyu
    Chen, Zhiwei
    Wu, Xiaojian
    Fan, Jian-Bing
    Gao, Feng
    Lan, Ping
    MOLECULAR ONCOLOGY, 2021, 15 (10) : 2702 - 2714
  • [3] A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
    Salta, Sofia
    Nunes, Sandra P.
    Fontes-Sousa, Mario
    Lopes, Paula
    Freitas, Micaela
    Caldas, Margarida
    Antunes, Luis
    Castro, Fernando
    Antunes, Pedro
    de Sousa, Susana Palma
    Henrique, Rui
    Jeronimo, Carmen
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (11)
  • [4] Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer
    Ying, Lee
    Sharma, Anup
    Chhoda, Ankit
    Ruzgar, Nensi
    Hasan, Nesrin
    Kwak, Ruby
    Wolfgang, Christopher L.
    Wang, Tza Huei
    Kunstman, John W.
    Salem, Ronald R.
    Wood, Laura D.
    Iacobuzio-Donahue, Christine
    Schneider, Eric B.
    Farrell, James J.
    Ahuja, Nita
    PANCREAS, 2021, 50 (09) : 1267 - 1273
  • [5] Cell-free DNA methylation-based preeclampsia prediction: A journey to improve maternal health
    Mio, Aerden
    Marie, De Borre
    Bernard, Thienpont
    PRENATAL DIAGNOSIS, 2024, 44 (04) : 418 - 421
  • [6] DNA Methylation Levels in Maternal, Fetal and Cell-Free DNA.
    Phillippe, Mark
    Adeli, Sharareh
    REPRODUCTIVE SCIENCES, 2018, 25 : 112A - 113A
  • [7] Systematic evaluation of methylation-based cell type deconvolution methods for plasma cell-free DNA
    Sun, Tongyue
    Yuan, Jinqi
    Zhu, Yacheng
    Li, Jingqi
    Yang, Shen
    Zhou, Junpeng
    Ge, Xinzhou
    Qu, Susu
    Li, Wei
    Li, Jingyi Jessica
    Li, Yumei
    GENOME BIOLOGY, 2024, 25 (01):
  • [8] Detection and quantification by homogeneous PCR of cell-free fetal DNA in maternal plasma
    Wei, CW
    Saller, DN
    Sutherland, JWH
    CLINICAL CHEMISTRY, 2001, 47 (02) : 336 - 338
  • [9] Detection of cell-free fetal DNA in maternal urine
    Illanes, S.
    Denbow, M. L.
    Smith, R. P.
    Overton, T. G.
    Soothill, P. W.
    Finning, K.
    PRENATAL DIAGNOSIS, 2006, 26 (13) : 1216 - 1218
  • [10] Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma
    Zhou, Yi
    Zhu, Zhongyi
    Gao, Ya
    Yuan, Yuying
    Guo, Yulai
    Zhou, Lijun
    Liao, KaiKai
    Wang, Jun
    Du, Bole
    Hou, Yumei
    Chen, Zhonglin
    Chen, Fang
    Zhang, Hongyun
    Yu, Cong
    Zhao, Lijian
    Lau, T. K.
    Jiang, Fuman
    Wang, Wei
    REPRODUCTIVE SCIENCES, 2015, 22 (11) : 1429 - 1435